NOVO — August 2025
-
Pæne udsving i
Novo/Zealand indenfor miutter - nogen set hvorfor? -
@Svingtraderen - denne måske? Health Canada approves Ozempic
to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. -
Ozempic
is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control and to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.1 -
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control and to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD).1
Yahoo Finance (finance.yahoo.com)
-
Her: Viking T afslører skuffende fedme data - falder 30%
-
Skuffende konkurrentdata sender Novo og Zealand Pharma op https://proinvestor.com/boards/127881
-
@pjl. Nu er det jo sjældent markedet er opjektivt rationelt og en pris er jo bare en elastik for midlertidig udbud/efterspørgsel. Hvis casen får sit naturlige momentum som så ofte før, så er kurs 400 jo peanuts og inden for rækkevidde inden for et par uger. et par positive nyheder .. bom ! Det store slagsmål bliver brud af kurs 630. En gammel bekendt.
-
Novo: Bestyrelsesmedlem køber ADR'er for godt 820.000 kr.
Christina Law, der er medlem af bestyrelsen hos Novo Nordisk, har købt samlet 2350 af medicinalselskabets amerikanske ADR'er.
De er blevet indkøbt for en samlet pris på 820.252,49 kr., fremgår det af en insidermeddele... -
-
Mht. ØU. Hvor ville det være dejligt om man fik den mindste dokumentation på hvad kursmålet er baseret på. Set fra den vinkel er kursmålet fuldstændig værdiløst og udtryk for en løs takegang = ubrugeligt. Men de øvrige forhold og betragtninger tager man da med i sit beslutningsgrundlag.
-
Er Novos data stærkere end aktiekursens nedtur udtrykker? https://proinvestor.com/boards/127888/
-
God fest. Ærgerligt at det samme ikke gælder for aktionærerne https://ekstrabladet.dk/underholdning/kultur/novo-nordisk-holder-sin-stoerste-firmafest-nogensinde-her-er-det-vilde-program/10916436
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind